Related Experiment Video
Updated: Sep 9, 2025

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Indications for and Optimal Management of Percutaneous Cholecystostomy Drainage: A Systematic Review
Aymen H Sadaka1,2, Jennifer F Tseng2, Kamal M F Itani1,2,3
1Department of Surgery, Veterans Affairs Boston Health Care System, Boston, Massachusetts.
Insights
Percutaneous cholecystostomy (PC) is best for poor surgical candidates, offering no benefit over antibiotics unless sepsis is present. Interval cholecystectomy within 8-13 weeks post-PC improves outcomes.
Area of Science:
- Gastroenterology and Hepatology
- Interventional Radiology
- Surgical Innovation
Background:
- Percutaneous cholecystostomy (PC) use has risen without clear guidelines.
- Indications and optimal management strategies for PC remain debated.
Purpose of the Study:
- To identify indicators for PC procedures.
- To clarify percutaneous cholecystostomy tube (PCT) management.
- To suggest optimal timing for subsequent interventions.
Main Methods:
- Systematic review of five databases (PubMed, Embase, Cochrane, ICTRP, ClinicalTrials.gov).
- Inclusion of systematic reviews, meta-analyses, RCTs, cohort studies, and case-control studies published within the last 5 years.
- Analysis of 69 studies from 3774 identified publications.
Main Results:
- PC is outperformed by cholecystectomy and offers no benefit over antibiotic-only management (AOM) except in sepsis.
- Interval cholecystectomy (IC) after PC yields better outcomes than definitive PC.
- Factors like CHF and CLD impede IC; IC within 8-13 weeks post-PC is optimal.
- PCT clamping trial superior to cholangiogram for tube removal.
Conclusions:
- PC is a bridging therapy for poor surgical candidates, indicated for cholecystitis, sepsis, or AOM failure.
- Careful consideration is needed for patients with CHF and CLD.
- Successful PCT clamping trial guides removal before IC (8-13 weeks) to reduce complications and recurrence.
Importance:
Use of percutaneous cholecystostomy (PC) has increased over the past 20 years without consensus regarding indications and management.
Objective:
To identify indicators for PC, clarify the management of a PC tube (PCT), and suggest the timing of further interventions.
Evidence Review:
A systematic review was conducted to identify studies examining PC. Five databases were selected and searched from inception to December 31, 2024: PubMed, Embase, Cochrane, ICTRP, and ClinicalTrials.gov. Inclusion criteria were prior systematic reviews and meta-analyses published within the last 5 years, randomized clinical trials, prospective cohort studies, retrospective cohorts, cross-sectional studies, and case-control studies with multivariate analyses.
Findings:
Of 3774 publications identified, 69 studies met the inclusion criteria. There were 5 randomized clinical trials, 2 prospective cohort analyses, 40 retrospective cohort analyses, 1 case-control study, 12 cross-sectional studies, 3 systematic reviews, and 6 meta-analyses. PC was outperformed by cholecystectomy and offered no apparent benefit compared to antibiotic-only management (AOM) except among patients with concomitant sepsis. Interval cholecystectomy (IC) following PC was associated with better outcomes compared to a definitive PC. Factors associated with failure to undergo IC include congestive heart failure (CHF) and chronic liver disease (CLD). IC within 8 weeks and beyond 13 weeks after PC was associated with increased complications. Removal of PC before IC was associated with reduced complications but an increase in the likelihood of undergoing emergency IC. A PCT clamp trial was a better test than tube cholangiogram for PCT removal.
Conclusion And Relevance:
PC should only be considered among poor surgical candidates unable to undergo immediate cholecystectomy. Indications for PC include cholecystitis sepsis or AOM failure. PC should be approached as a bridging therapy to IC with careful consideration among patients with CHF and CLD. PC removal before IC should be guided by a successful clamping trial to reduce complications and interim recurrence. IC should be performed 8 to 13 weeks after PC.
Related Concept Videos
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Acute Pancreatitis II: Clinical Manifestations and Management
Endoscopic Procedures V: ERCP
Patient...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Aneurysm IV: Nursing Management
Chronic Pancreatitis II: Collaborative Care
Assessment:

